Published in Cancer Weekly, July 31st, 2007
"These preliminary findings are an important step in the development of our first commercial offering - diagnostic assays that enable patient- friendly, cost-effective monitoring and personalized management of bladder cancer survivors," said Eugene Chiu, vice president of business development. "These results also...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.